Suzanne M. Lloyd

2.7k total citations
42 papers, 1.7k citations indexed

About

Suzanne M. Lloyd is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Suzanne M. Lloyd has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Suzanne M. Lloyd's work include Blood Pressure and Hypertension Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Heart Failure Treatment and Management (4 papers). Suzanne M. Lloyd is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Heart Failure Treatment and Management (4 papers). Suzanne M. Lloyd collaborates with scholars based in United Kingdom, Netherlands and United States. Suzanne M. Lloyd's co-authors include Ian Ford, Alex McConnachie, Naveed Sattar, Fiona Moreton, Xuya Huang, Keith W. Muir, Bharath Kumar Cheripelli, Dheeraj Kalladka, David Preiss and Chris J. Packard and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Stroke.

In The Last Decade

Suzanne M. Lloyd

42 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne M. Lloyd United Kingdom	23	516	402	302	233	199	42	1.7k
N. David Yanez United States	28	416 0.8×	469 1.2×	423 1.4×	115 0.5×	163 0.8×	59	2.6k
Sung Sug Yoon United States	16	575 1.1×	883 2.2×	171 0.6×	257 1.1×	217 1.1×	22	2.2k
Tracy E. Madsen United States	26	967 1.9×	347 0.9×	372 1.2×	168 0.7×	121 0.6×	92	2.2k
Ana C. Ricardo United States	34	382 0.7×	652 1.6×	329 1.1×	306 1.3×	311 1.6×	93	3.3k
Stanley Ip United States	26	372 0.7×	680 1.7×	580 1.9×	240 1.0×	159 0.8×	46	2.7k
Christina M. Parrinello United States	19	363 0.7×	338 0.8×	170 0.6×	139 0.6×	502 2.5×	48	1.8k
Valeria Saglimbene Australia	25	270 0.5×	239 0.6×	159 0.5×	160 0.7×	210 1.1×	51	2.2k
Jorma Torppa Finland	28	867 1.7×	1.0k 2.6×	319 1.1×	325 1.4×	204 1.0×	59	2.7k
Antoni Sicras‐Mainar Spain	23	554 1.1×	224 0.6×	199 0.7×	280 1.2×	209 1.1×	153	2.0k
Josep Ramón Marsal Spain	24	376 0.7×	624 1.6×	369 1.2×	281 1.2×	191 1.0×	97	1.7k

Countries citing papers authored by Suzanne M. Lloyd

Since Specialization

Citations

This map shows the geographic impact of Suzanne M. Lloyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne M. Lloyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne M. Lloyd more than expected).

Fields of papers citing papers by Suzanne M. Lloyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne M. Lloyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne M. Lloyd. The network helps show where Suzanne M. Lloyd may publish in the future.

Co-authorship network of co-authors of Suzanne M. Lloyd

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne M. Lloyd. A scholar is included among the top collaborators of Suzanne M. Lloyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne M. Lloyd. Suzanne M. Lloyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gray, Cindy M., Sally Wyke, Annie S. Anderson, et al.. (2018). Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study. SHILAP Revista de lepidopterología. 6(9). 1–114. 27 indexed citations

Meredith, Peter, Suzanne M. Lloyd, Ian Ford, & Henry L. Elliott. (2016). Importance of sustained and “tight” blood pressure control in patients with high cardiovascular risk. Blood Pressure. 25(2). 74–82. 10 indexed citations

Mercer, Stewart W, Maria Higgins, Bridie Fitzpatrick, et al.. (2016). General Practitioners’ Empathy and Health Outcomes: A Prospective Observational Study of Consultations in Areas of High and Low Deprivation. The Annals of Family Medicine. 14(2). 117–124. 100 indexed citations

Elliott, Henry L., Suzanne M. Lloyd, Ian Ford, & Peter Meredith. (2016). Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system. Blood Pressure. 25(2). 67–73. 1 indexed citations

Mercer, Stewart W, Bridie Fitzpatrick, Bruce Guthrie, et al.. (2016). The CARE Plus study – a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis. BMC Medicine. 14(1). 88–88. 98 indexed citations

Böhm, Michael, Suzanne M. Lloyd, Ian Ford, et al.. (2016). Non-Adherence to Ivabradine and Placebo and Outcomes in Chronic Heart Failure: An Analysis from SHIFT. European Journal of Heart Failure. 18(6). 672–683. 15 indexed citations

Böhm, Michael, Jeffrey Borer, A. John Camm, et al.. (2015). Twenty-Four-Hour Heart Rate Lowering with Ivabradine in Chronic Heart Failure: Insights from the SHIFT Holter Substudy. European Journal of Heart Failure. 17(5). 518–526. 51 indexed citations

Macfarlane, Peter W., Suzanne M. Lloyd, Dilbag Singh, et al.. (2015). Normal limits of the electrocardiogram in Indians. Journal of Electrocardiology. 48(4). 652–668. 15 indexed citations

Huang, Xuya, Bharath Kumar Cheripelli, Suzanne M. Lloyd, et al.. (2015). Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study. The Lancet Neurology. 14(4). 368–376. 208 indexed citations

10.

Poortvliet, Rosalinde K.E., Suzanne M. Lloyd, Ian Ford, et al.. (2014). Biological Correlates of Blood Pressure Variability in Elderly at High Risk of Cardiovascular Disease. American Journal of Hypertension. 28(4). 469–479. 10 indexed citations

11.

Macfarlane, Peter W., Satish T. Hamde, Dilbag Singh, et al.. (2014). Racial differences in the ECG — selected aspects. Journal of Electrocardiology. 47(6). 809–814. 43 indexed citations

12.

Lowrie, Richard, Suzanne M. Lloyd, Alex McConnachie, & Jill Morrison. (2014). A Cluster Randomised Controlled Trial of a Pharmacist-Led Collaborative Intervention to Improve Statin Prescribing and Attainment of Cholesterol Targets in Primary Care. PLoS ONE. 9(11). e113370–e113370. 34 indexed citations

13.

Abrahamsson, Putte, Karl Swedberg, Jeffrey Borer, et al.. (2013). Risk Following Hospitalization in Stable Chronic Systolic Heart Failure. European Journal of Heart Failure. 15(8). 885–891. 35 indexed citations

14.

Lloyd, Suzanne M., Alex McConnachie, Richard Fleming, et al.. (2013). External validation of anti-Müllerian hormone based prediction of live birth in assisted conception. Journal of Ovarian Research. 6(1). 3–3. 41 indexed citations

15.

Preiss, David, Suzanne M. Lloyd, Ian Ford, et al.. (2013). Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial. The Lancet Diabetes & Endocrinology. 2(2). 116–124. 141 indexed citations

16.

Mackay, Daniel, Sally Haw, David E. Newby, et al.. (2013). Impact of Scotland’s Comprehensive, Smoke-Free Legislation on Stroke. PLoS ONE. 8(5). e62597–e62597. 18 indexed citations

17.

Poortvliet, Rosalinde K. E., Ian Ford, Suzanne M. Lloyd, et al.. (2012). Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS ONE. 7(12). e52438–e52438. 61 indexed citations

18.

Clark, Elaine, et al.. (2010). Comparison of QRS duration in African blacks and European Caucasians. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 701–704. 5 indexed citations

19.

Lloyd, Suzanne M., Sylwia Bujkiewicz, Allan Wailoo, Alex J. Sutton, & David L. Scott. (2010). The effectiveness of anti-TNF- therapies when used sequentially in rheumatoid arthritis patients: a systematic review and meta-analysis. Lara D. Veeken. 49(12). 2313–2321. 49 indexed citations

20.

Lloyd, Suzanne M., et al.. (1998). Education and adherence to therapy in a clinical setting. European Respiratory Review. 8(58). 333–337. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact